Redesigning the designer drug ecstasy:Non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity
Gandy, Michael N; McIldowie, Matthew; Lewis, Katie; Wasik, Agata M; Salomonczyk, Danielle; Wagg, Keith; Millar, Zak A; Tindiglia, David; Huot, Philippe; Johnston, Tom; Thiele, Sherri; Brotchie, Jonathan M
Burkitt's lymphoma (BL) is a particularly aggressive cancer that primarily affects African children. Unfortunately, effective and affordable treatment is out of reach of most of the afflicted. The illicit psychoactive drug methylenedioxymethamphetamine (MDMA, 'ecstasy') is cytotoxic to BL cell lines, but its low potency, psychoactivity and neurotoxicity preclude consideration as a therapeutic drug candidate. This paper describes the discovery of novel α-aryl analogues of MDMA that lack...[Show more]
|Collections||ANU Research Publications|
|01_Gandy_Redesigning_the_designer_drug_2010.pdf||172 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.